![WCLC News Post Edition](/sites/default/files/styles/d08_traditional/public/2021-10/21-WCLC-Post-FeatureImage%20copy.jpg?h=827069f2&itok=pqleXcHn)
WCLC News Digital Edition
WCLC 2021 Post Edition
What's inside?
- Lurbinectedin use in patients with platinum-sensitive SCLC
- Pretreatment ctDNA as a prognostic marker in stage IIIA NSCLC
- Surgery for stage IIIA-N2 NSCLC
- PLCO screening model for lung cancer detection
- Increased access to care for MPM linked to likelihood of surgery
- Age does not appear to affect benefit of ICIs for stage IV NSCLC
- COVID-19 complications in lung cancer patients
- Air pollution a factor in fight against lung cancer
- Covid-19 slows lung cancer trials globally
WCLC 2021 Press Briefings
Advocacy, Stigma, and Disparities
![What are the REAL Barriers to Clinical Trials Participation](/sites/default/files/styles/d08_standard/public/2021-09/Real%20Barriers%20.jpg?h=7531a71b&itok=YaAlWG-5)